These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8474497)

  • 1. Function of dopamine receptors in young-onset Parkinson's disease: prolactin response.
    Kostic VS; Marinkovic Z; Filipovic S; Momcilovic D
    Mov Disord; 1993 Apr; 8(2):227-9. PubMed ID: 8474497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Patients with Parkinson disease: functional analysis of dopamine receptors by bromocriptine- thyrotropin-releasing hormone test].
    Díaz F; Liberman C; Chariá P
    Rev Med Chil; 1991 Mar; 119(3):252-7. PubMed ID: 1842116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic dysfunction in Parkinson's disease patients.
    Otake K; Oiso Y; Mitsuma T; Hirooka Y; Adachi K
    Acta Med Hung; 1994; 50(1-2):3-13. PubMed ID: 7638039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamo-pituitary function and dopamine dependence in untreated parkinsonian patients.
    Cusimano G; Capriani C; Bonifati V; Meco G
    Acta Neurol Scand; 1991 Mar; 83(3):145-50. PubMed ID: 1903236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin response to thyrotropin-releasing hormone as a guideline for cyclical mastalgia treatment.
    Rea N; Bove F; Gentile A; Parmeggiani U
    Minerva Med; 1997 Nov; 88(11):479-87. PubMed ID: 9433398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function of dopamine receptors in Parkinson's disease: prolactin responses.
    Laihinen A; Rinne UK
    Neurology; 1986 Mar; 36(3):393-5. PubMed ID: 3081830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pyridostigmine on the thyroid-stimulating hormone response to thyrotropin-releasing hormone in abstinent alcoholics.
    Coiro V; Vescovi PP
    Alcohol Clin Exp Res; 1997 Oct; 21(7):1308-11. PubMed ID: 9347094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine receptor function in Parkinson's disease--in vivo studies with prolactin responses.
    Laihinen A; Rinne UK
    Adv Neurol; 1987; 45():249-52. PubMed ID: 3103387
    [No Abstract]   [Full Text] [Related]  

  • 9. Sulpiride and thyrotrophin releasing hormone loading test in patients with acromegaly.
    Zséli J; Földes J; Holló I; Kollin E; Horváth C; Gács G; Borvendég J
    Acta Med Acad Sci Hung; 1980; 37(4):357-64. PubMed ID: 6785978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary function and the somatotrophic system in patients with idiopathic Parkinson's disease under chronic dopaminergic therapy.
    Schaefer S; Vogt T; Nowak T; Kann PH;
    J Neuroendocrinol; 2008 Jan; 20(1):104-9. PubMed ID: 18081558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRH test and the continuous dopaminergic stimulation in complicated Parkinson's disease.
    Lestingi L; Bonifati V; Stocchi F; Antonozzi I; Meco G
    Eur Neurol; 1992; 32(2):65-9. PubMed ID: 1563463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The extracerebral dopamine antagonist domperidone block the suppressive effect of bromocriptine on prolactin and TSH secretion in man.
    Svet-Moldavsky I; Svet-Moldavsky G; Zinzar S; Holland J; Vergara C; Arlin Z; Koziner B; Clarkson B
    Biomedicine; 1981 Oct; 35(5):142-4. PubMed ID: 6797487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic-pituitary-adrenal axis function in patients with active rheumatoid arthritis: a controlled study using insulin hypoglycemia stress test and prolactin stimulation.
    Gutiérrez MA; García ME; Rodriguez JA; Mardonez G; Jacobelli S; Rivero S
    J Rheumatol; 1999 Feb; 26(2):277-81. PubMed ID: 9972958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pyridostigmine and naloxone on the abnormal TSH response to TRH during starvation in humans.
    Coiro V; Volpi R; Capretti L; Caffarri G; Colla R; Chiodera P
    J Investig Med; 1999 May; 47(5):227-31. PubMed ID: 10361382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced Gs protein function and G alpha s levels in leukocytes of patients with Parkinson's disease.
    Avissar S; Barki-Harrington L; Herishanu Y; Schreiber G
    Mov Disord; 1997 Mar; 12(2):167-74. PubMed ID: 9087974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma prolactin response to submaximal stimulation by TRH and endogenous corticosteroids in man.
    Spoov J
    Pharmacopsychiatry; 1987 May; 20(3):96-8. PubMed ID: 3110801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain receptor changes in Parkinson's disease in relation to the disease process and treatment.
    Rinne UK; Rinne JO; Rinne JK; Laakso K; Laihinen A; Lönnberg P
    J Neural Transm Suppl; 1983; 18():279-86. PubMed ID: 6308149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prolactin-releasing mechanism of the hypothalamo-pituitary axis in pregnancy.
    Kubota T; Yaoi Y; Nagae M; Kumasaka T; Saito M
    Fertil Steril; 1984 Nov; 42(5):724-9. PubMed ID: 6436068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of the hypothalamo-pituitary axis in rheumatoid arthritis.
    Jorgensen C; Bressot N; Bologna C; Sany J
    J Rheumatol; 1995 Oct; 22(10):1829-33. PubMed ID: 8991978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Executive function in Parkinson's disease].
    Kanazawa A; Mizuno Y; Narabayashi H
    Rinsho Shinkeigaku; 2001; 41(4-5):167-72. PubMed ID: 11676156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.